Keyword: Food and Drug Administration (FDA)

News

More Lawsuits Target US Merck’s Shingles Vaccine

26.07.2017 - US Merck’s shingles (herpes zoster) vaccine Zostavax continues to be the target of legal action at a time when the drugmaker is already facing the prospect of competition from...

News

FDA Approves New Breast Cancer Treatment

19.07.2017 - The US Food and Drug Administration (FDA) has approved Nerlynx (neratinib), made by Puma Biotechnology for the extended adjuvant treatment of early-stage, HER2-positive breast...

News

Sanofi to Acquire Protein Sciences in US

13.07.2017 - French drugmaker Sanofi is gaining access to a new type of flu vaccine after agreeing to buy Protein Sciences, a privately held vaccines biotechnology company based in Meriden...

News

FDA Stops US Merck Keytruda Trials

12.07.2017 - The US Food and Drug Administration (FDA) has placed a clinical hold on three phase 3 multiple myeloma studies testing US drugmaker Merck’s Keytruda (pembrolizumab) in combination...

News

Journalists Unhappy with Drugmaker Communications

22.06.2017 - In unusually open criticism of a sector journalists report on widely, the digital communications platform ISEBOX has accused the international pharmaceutical industry of failing to...

News

Cambrex Hikes High Point Capacity

22.05.2017 - US life science company Cambrex is adding a fourth reactor suite at its site in High Point, North Carolina, expanding pilot plant capabilities to meet rising demand. The investment...

News

Biogen Licenses Remedy’s Stroke Drug

19.05.2017 - Biogen has licensed a late-stage stroke drug from Remedy Pharmaceuticals. The US biotech will make an upfront payment of $120 million for Cirara (intravenous glyburide), as well as...

News

Novartis Takes Rights to Conatus NASH Drug

15.05.2017 - Swiss pharma company Novartis has exercised an option that gives it global development and commercialization rights to a drug being developed by US biotech Conatus Pharmaceuticals...